These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34608880)

  • 1. Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms.
    Abou-Ismail MY; Prchal JT; Deininger MW; Parker CJ; Lim MY
    Blood Coagul Fibrinolysis; 2021 Dec; 32(8):578-583. PubMed ID: 34608880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension.
    Reilly CR; Babushok DV; Martin K; Spivak JL; Streiff M; Bahirwani R; Mondschein J; Stein B; Moliterno A; Hexner EO
    Am J Hematol; 2017 Sep; 92(9):909-914. PubMed ID: 28543980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension.
    Slowik V; Monroe EJ; Friedman SD; Hsu EK; Horslen S
    Pediatr Transplant; 2019 May; 23(3):e13387. PubMed ID: 30932316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
    De Stefano V; Qi X; Betti S; Rossi E
    Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.
    Yan M; Geyer H; Mesa R; Atallah E; Callum J; Bartoszko J; Yee K; Maganti M; Wong F; Gupta V
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e1-5. PubMed ID: 25027569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis.
    Jiao P; Chen XY; Zheng HY; Qin J; Li C; Zhang XL
    Medicine (Baltimore); 2022 Jul; 101(26):e29742. PubMed ID: 35777012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Artru F; Moschouri E; Denys A
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101858. PubMed ID: 34999250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splanchnic vein thrombosis].
    Riescher-Tuczkiewicz A; Elkrief L; Rautou PE
    Rev Med Interne; 2024 Jan; 45(1):17-25. PubMed ID: 37838484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous mesocaval shunt creation for portal thrombosis in a patient with a JAK2V617F mutation.
    Farhan A; Liddell RP
    Thromb Res; 2024 Feb; 234():158-161. PubMed ID: 38241766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of splanchnic vein thrombosis.
    Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
    JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.
    Senzolo M; Tibbals J; Cholongitas E; Triantos CK; Burroughs AK; Patch D
    Aliment Pharmacol Ther; 2006 Mar; 23(6):767-75. PubMed ID: 16556179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
    Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?
    Riggio O; Ridola L; Lucidi C; Angeloni S
    Dig Liver Dis; 2010 Jul; 42(7):462-7. PubMed ID: 20036625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation.
    Gao J; Ran HT; Ye XP; Zheng YY; Zhang DZ; Wang ZG
    Clin Imaging; 2012; 36(2):135-41. PubMed ID: 22370134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
    Parker R
    Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China.
    Lv Y; Fan D; Han G
    Liver Int; 2023 Jan; 43(1):18-33. PubMed ID: 35593016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
    Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.